Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP by country
Countries reporting
26
Highest
15.2
China
Lowest
0
Spain
Median
0
Years covered
12
2009–2020
Data points
454
What the numbers show
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP is currently reported for 26 countries. The highest value is 15.2 in China; the lowest is 0 in Spain.
The median across all reporting countries is 0, and the mean is 1.72.
Proportion of isolates with decreased susceptibility or resistance: full country ranking
| # | Country | Latest | Year | 10-year change | Trend |
|---|---|---|---|---|---|
| 1 | China | 15.2 | 2020 | down 58.9% | volatile |
| 2 | Cuba | 6.9 | 2019 | — | volatile |
| 3 | Malaysia | 6.8 | 2020 | down 32.0% | volatile |
| 4 | Viet Nam | 6.09 | 2017 | — | volatile |
| 5 | Japan | 3.7 | 2020 | — | volatile |
| 6 | Singapore | 2.2 | 2020 | — | volatile |
| 7 | Canada | 1.4 | 2020 | down 80.9% | volatile |
| 8 | Bhutan | 1 | 2020 | down 54.7% | volatile |
| 9 | Mongolia | 0.7752 | 2018 | down 95.9% | volatile |
| 10 | Belgium | 0.6 | 2020 | — | volatile |
| 11 | New Zealand | 0.1 | 2020 | — | volatile |
| 12 | Australia | 0.01 | 2020 | down 91.9% | volatile |
| 13 | Ireland | 0 | 2020 | — | volatile |
| 13 | Argentina | 0 | 2020 | — | volatile |
| 13 | Korea | 0 | 2018 | down 100.0% | volatile |
| 13 | Germany | 0 | 2020 | — | volatile |
| 13 | Austria | 0 | 2020 | — | volatile |
| 13 | India | 0 | 2020 | down 100.0% | volatile |
| 13 | Pakistan | 0 | 2019 | — | volatile |
| 13 | Peru | 0 | 2020 | — | volatile |
| 13 | Philippines | 0 | 2020 | — | volatile |
| 13 | Greece | 0 | 2020 | — | volatile |
| 13 | Slovenia | 0 | 2020 | — | volatile |
| 13 | Thailand | 0 | 2020 | down 100.0% | volatile |
| 13 | United States of America | 0 | 2020 | down 100.0% | volatile |
| 13 | Spain | 0 | 2020 | — | volatile |